Caricamento...
Second line trastuzumab emtansine following horizontal dual blockade in a real-life setting
Despite relevant medical advancements, metastatic breast cancer remains an uncurable disease. HER2 signaling conditions tumor behavior and treatment strategies of HER2 expressing breast cancer. Cancer treatment guidelines uniformly identify dual blockade with pertuzumab and trastuzumab plus a taxane...
Salvato in:
Pubblicato in: | Oncotarget |
---|---|
Autori principali: | , , , , , , , , , , , , , , |
Natura: | Artigo |
Lingua: | Inglês |
Pubblicazione: |
Impact Journals LLC
2020
|
Soggetti: | |
Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7275781/ https://ncbi.nlm.nih.gov/pubmed/32547706 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27603 |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|